CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Current Assets:
Cash	$ 4,298	$ 28,897
Prepaid	6,500
Prepaid stock compensation		7,980
Total Current Assets	10,798	36,877
Total Assets	10,798	36,877
Current Liabilities:
Accounts payable		3,500
Accrued compensation		25,500
Loans payable	14,165	14,165
Interest payable	13,029	3,889
Convertible notes payable, net of debt discount of $5,210 and $91,100, respectively	166,234	47,844
Derivative liability		88,169
Total Current Liabilities	193,428	183,067
Total Liabilities	193,428	183,067
Stockholders’ Equity (Deficit):
Preferred Stock, $0.001 par value, 10,000,000 shares authorized, no shares issued
Common Stock, $0.001 par value, 5,000,000,000 shares authorized; 30,238,686 and 24,692,459 shares issued and outstanding, respectively	$ 30,239	$ 24,693
Common stock to be issued	58,938
Additional paid in capital	$ 17,243,603	$ 16,945,642
Accumulated deficit	(17,515,410)	(17,116,525)
Total Stockholders' Equity (Deficit)	(182,630)	(146,190)
Total Liabilities and Stockholders' Deficit	$ 10,798	$ 36,877

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.